As of September 2025, the firm held stakes in 12 BSE-listed companies, with the portfolio valued at Rs 66,655 crorea rise of 11% from Rs 60,221 crore in March 2025.
Indian equity markets are likely to remain range-bound in the near term as investors await clearer signals on earnings recovery, the rupees trajectory and progress on the IndiaUS trade deal, says Ashi Anand. He believes clarity on these factors could set the stage for the next phase of the bull run.
Infosys ADRs surged as much as 40% on the NYSE before trading was halted twice, despite the company denying any material trigger. A Canada-based report attributed the spike to a bizarre ticker-mapping glitch that may have confused automated trading systems amid thin year-end liquidity.
Nifty logged its third consecutive weekly loss within a tight 321-point range, reflecting market indecision. Analyst Sudeep Shah sees key support at 25,77025,700 and resistance at 26,05026,100, with Nifty poised to target 27,000 in 2026. Bank Nifty and sectors like IT, Auto, and Metals show strength amid ongoing volatility.
Infosys ADRs surged 40% on the NYSE, hitting a 52-week high of $30 and triggering two trading halts. Analysts cite a combination of a short squeeze, automated trading glitches, and low holiday liquidity. Infosys clarified there were no material developments behind the sharp spike.
Thirteen small-cap stocks, including Kothari Industrial and Wardwizard Innovations, recorded losses for five consecutive sessions, with declines ranging from 5% to 23% amid broader market weakness.
In a challenging 2025, Vijay Kedia and Mukul Agrawal spotted six multibagger stocks, including OSEL Devices and Zelio E-Mobility, that delivered exceptional returns despite a tough market for smallcaps.
Next week, 11 IPOs, led by Gujarat Kidney and Shyam Dhani Industries, are set to open, with grey market premiums signalling potential listing gains of up to 57%.
